Surgery Partners Inc. (Nasdaq: SGRY) will remain an independent, publicly traded company following the conclusion of its strategic review process, executives reaffirmed during the company’s second quarter 2025 earnings call on Tuesday. Instead of pursuing a sale to Bain Capital, which had been under consideration prior to June 17, the company will pivot toward selectively selling or partnering assets to accelerate cash flow and reduce debt. “The special committee of independent directors’ … [Read more...]